Skip to main content
SpringerLink
Log in

The Woodchuck Model of HDV Infection

  • Chapter
Hepatitis Delta Virus

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 307))

Abstract

The Eastern woodchuck, Marmota monax, has been a useful model system for the study of the natural history of hepadnavirus infection and for the development and preclinical testing of antiviral therapies. The model has also been used for hepatitis delta virus (HDV). In this chapter several new applications of the woodchuck model of HDV infection are presented and discussed. The development of a woodchuck HDV inoculum derived from a molecular clone has facilitated the analysis of viral genetic changes occurring during acute and chronic infection. This analysis has provided insights into one of the more important aspects of the natural history of HDV infection—whether a superinfection becomes chronic. These results could renew interest in further vaccine development. An effective therapy for chronic HDV infection remains an important clinical goal for this agent, particularly because of the severity of the disease and the inability of current hepadnaviral therapies to ameliorate it. The recent application of the woodchuck model of chronic HDV infection to therapeutic development has yielded promising results which indicate that targeting the hepadnavirus surface protein may be a successful therapeutic strategy for HDV.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bergmann KF, Casey JL, Tennant BC, Gerin JL (1993) Modulation of hepatitis delta virus infection by vaccination with synthetic peptides: a preliminary study in the woodchuck model. Prog Clin Biol Res 382:181–187

    PubMed  CAS  Google Scholar 

  • Bergmann KF, Cote PJ, Moriarty A, Gerin JL (1989) Hepatitis delta antigen. Antigenic structure and humoral immune response [published erratum appears in J Immunol 1990 Feb 1;144(3):1151]. J Immunol 143:3714–3721

    PubMed  CAS  Google Scholar 

  • Casey JL, Cote PJ, Toshkov IA, Chu CK, Gerin JL, Hornbuckle WE, Tennant BC, Korba BE (2005) Clevudine inhibits hepatitis delta virus viremia: a pilot study in chronically infected woodchucks. Antimicrob Agents Chemother 49: 4396–4399

    Article  PubMed  CAS  Google Scholar 

  • Chao YC, Tang HS, Hsu CT (1994) Evolution rate of hepatitis delta virus RNA isolated in Taiwan. J Med Virol 43:397–403

    PubMed  CAS  Google Scholar 

  • Choi SS, Rasshofer R, Roggendorf M (1988) Propagation of woodchuck hepatitis delta virus in primary woodchuck hepatocytes. Virology 167:451–457

    PubMed  CAS  Google Scholar 

  • D’Ugo E, Paroli M, Palmieri G, Giuseppetti R, Argentini C, Tritarelli E, Bruni R, Barnaba V, Houghton M, Rapicetta M (2004) Immunization of woodchucks with adjuvanted sHDAg (p24): immune response and outcome following challenge. Vaccine 22:457–466

    Article  PubMed  CAS  Google Scholar 

  • Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M (1995) A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 333:1657–1661

    Article  PubMed  CAS  Google Scholar 

  • Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder JC, Strazzera A, Chien DY, Munoz SJ, Balestrieri A and others (2000) The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288:339–344

    Article  PubMed  CAS  Google Scholar 

  • Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, Schalm SW (2000) Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut 46:420–426

    Article  PubMed  CAS  Google Scholar 

  • Feld J, Locarnini S (2002) Antiviral therapy for hepatitis B virus infections: new targets and technical challenges. J. Clin. Virol. 25:267–283

    Article  PubMed  CAS  Google Scholar 

  • Fiedler M, Lu M, Siegel F, Whipple J, Roggendorf M (2001) Immunization of woodchucks (Marmota monax) with hepatitis delta virus DNA vaccine. Vaccine 19:4618–4626

    Article  PubMed  CAS  Google Scholar 

  • Gerin JL, Casey JL, Purcell RH (2001) Hepatitis Delta Virus. In: Knipe DM, Howley PM, (eds) Field’s Virology. 4 ed. Lippincott, Williams & Wilkins, Philadelphia, PA, pp 3037–3050

    Google Scholar 

  • Imazeki F, Omata M, Ohto M (1990) Heterogeneity and evolution rates of delta virus RNA sequences. J Virol 64:5594–5599

    PubMed  CAS  Google Scholar 

  • Karayiannis P, Saldanha J, Jackson AM, Luther S, Goldin R, Monjardino J, Thomas HC (1993) Partial control of hepatitis delta virus superinfection by immunisation of woodchucks (Marmota monax) with hepatitis delta antigen expressed by a recombinant vaccinia or baculovirus. J Med Virol 41:210–214

    PubMed  CAS  Google Scholar 

  • Karayiannis P, Saldanha J, Monjardino J, Goldin R, Main J, Luther S, Easton M, Ponzetto A, Thomas HC (1990) Immunization of woodchucks with recombinant hepatitis delta antigen does not protect against hepatitis delta virus infection. Hepatology 12:1125–1128

    PubMed  CAS  Google Scholar 

  • Korba BE, Cote PJ, Menne S, Toshkov IA, Baldwin BH, Wells FV, Tennant BC, Gerin JL (2004) Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection. Antiviral Therapy 9:937–952

    PubMed  CAS  Google Scholar 

  • Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Wu PC, Dent JC, Barber J and others (1998) A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 339:61–68

    Article  PubMed  CAS  Google Scholar 

  • Lanford RE, Chavez D, Brasky KM, Burns RB, 3rd, Rico-Hesse R (1998) Isolation of a hepadnavirus from the woolly monkey, a New World primate. Proc Natl Acad Sci U S A 95:5757–5761

    Article  PubMed  CAS  Google Scholar 

  • Lau DT, Doo E, Park Y, Kleiner DE, Schmid P, Kuhns MC, Hoofnagle JH (1999) Lamivudine for chronic delta hepatitis. Hepatology 30:546–549

    Article  PubMed  CAS  Google Scholar 

  • Lee CM, Bih FY, Chao YC, Govindarajan S, Lai MM (1992) Evolution of hepatitis delta virus RNA during chronic infection. Virology 188:265–273

    Article  PubMed  CAS  Google Scholar 

  • Marcellin P, Mommeja-Marin H, Sacks SL, Lau GK, Sereni D, Bronowicki JP, Conway B, Trepo C, Blum MR, Yoo BC and others (2004) A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B. Hepatology 40:140–148

    Article  PubMed  CAS  Google Scholar 

  • Menne S, Roneker CA, Korba BE, Gerin JL, Tennant BC, Cote PJ (2002) Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-βL-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection. J Virol 76:5305–5314

    Article  PubMed  CAS  Google Scholar 

  • Negro F, Korba BE, Forzani B, Baroudy BM, Brown TL, Gerin JL, Ponzetto A (1989) Hepatitis delta virus (HDV) and woodchuck hepatitis virus (WHV) nucleic acids in tissues of HDV-infected chronic WHV carrier woodchucks. J Virol 63:1612–1618

    PubMed  CAS  Google Scholar 

  • Netter HJ, Kajino K, Taylor JM (1993) Experimental transmission of human hepatitis delta virus to the laboratory mouse. J Virol 67:3357–3362

    PubMed  CAS  Google Scholar 

  • Netter HJ, Wu TT, Bockol M, Cywinski A, Ryu WS, Tennant BC, Taylor JM (1995) Nucleotide sequence stability of the genome of hepatitis delta virus. J Virol 69:1687–1692

    PubMed  CAS  Google Scholar 

  • Nevens F, Main J, Honkoop P, Tyrrell DL, Barber J, Sullivan MT, Fevery J, De Man RA, Thomas HC (1997) Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study. Gastroenterology 113:1258–1263

    Article  PubMed  CAS  Google Scholar 

  • Niro GA, Rosina F, Rizzetto M (2005) Treatment of hepatitis D. J Viral Hepat 12:2–9

    Article  PubMed  CAS  Google Scholar 

  • Peek SF, Cote PJ, Jacob JR, Toshkov IA, Hornbuckle WE, Baldwin BH, Wells FV, Chu CK, Gerin JL, Tennant BC and others (2001) Antiviral activity of L-FMAU (1-(2-fluoro-5-methyl-b_L-arabinofuranosyl) uracil) against WHV replication and gene expression in chronically infected woodchucks. Hepatology 33:254–266

    Article  PubMed  CAS  Google Scholar 

  • Ponzetto A, Cote PJ, Popper H, Hoyer BH, London WT, Ford EC, Bonino F, Purcell RH, Gerin JL (1984) Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck. Proc Natl Acad Sci U S A 81:2208–2212

    Article  PubMed  CAS  Google Scholar 

  • Ponzetto A, Forzani B, Smedile A, Hele C, Avanzini L, Novara R, Canese MG (1987) Acute and chronic delta infection in the woodchuck. Prog Clin Biol Res 234:37–46

    PubMed  CAS  Google Scholar 

  • Purcell RH, Satterfield WC, Bergmann KF, Smedile A, Ponzetto A, Gerin JL (1987) Experimental hepatitis delta virus infection in the chimpanzee. In: Rizzetto M, Gerin JL, Purcell RH, (eds) The hepatitis delta virus and its infection. Alan R. Liss, New York, pp 27–36

    Google Scholar 

  • Rizzetto M, Hoyer B, Canese MG, Shih JW, Purcell RH, Gerin JL (1980) delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci U S A 77:6124–6128

    Article  PubMed  CAS  Google Scholar 

  • Rizzetto M, Verme G, Recchia S, Bonino F, Farci P, Arico S, Calzia R, Picciotto A, Colombo M, Popper H (1983) Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med 98:437–441

    PubMed  CAS  Google Scholar 

  • Ryu WS, Bayer M, Taylor J (1992) Assembly of hepatitis delta virus particles. J Virol 66:2310–2315

    PubMed  CAS  Google Scholar 

  • Schlipkoter U, Ponzetto A, Fuchs K, Rasshofer R, Choi SS, Roos S, Rapicetta M, Roggendorf M (1990) Different outcomes of chronic hepatitis delta virus infection in woodchucks. Liver 10:291–301

    PubMed  CAS  Google Scholar 

  • Smedile A, Casey JL, Cote PJ, Durazzo M, Lavezzo B, Purcell RH, Rizzetto M, Gerin JL (1998) Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope. Hepatology 27:1723–1729

    Article  PubMed  CAS  Google Scholar 

  • Smedile A, Rizzetto M, Gerin JL (1994) Advances in hepatitis D virus biology and disease. Prog Liver Dis 12:157–175

    PubMed  CAS  Google Scholar 

  • Taylor J, Mason W, Summers J, Goldberg J, Aldrich C, Coates L, Gerin J, Gowans E (1987) Replication of human hepatitis delta virus in primary cultures of woodchuck hepatocytes. J Virol 61:2891–2895

    PubMed  CAS  Google Scholar 

  • Tennant BC, Gerin JL (1994) The woodchuck model of hepatitis B virus infection. In: Shafritz DA, (ed) The Liver: Biology and Pathology. 3rd ed. Raven Press, Ltd., New York, pp 1455–1466

    Google Scholar 

  • Wang JG, Jansen RW, Brown EA, Lemon SM (1990) Immunogenic domains of hepatitis delta virus antigen: peptide mapping of epitopes recognized by human and woodchuck antibodies. J Virol 64:1108–1116

    PubMed  CAS  Google Scholar 

  • Wolters LM, van Nunen AB, Honkoop P, Vossen AC, Niesters HG, Zondervan PD, de Man RA (2000) Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus. J Viral Hepatitis 7:428–434

    Article  CAS  Google Scholar 

  • Wright TL, Pereira B (1995) Liver transplantation for chronic viral hepatitis. Liver Transplant Surg 1:30–42

    Article  CAS  Google Scholar 

  • Yurdaydin C, Bozkaya H, Gurel S, Tillmann HL, Aslan N, Okcu-Heper A, Erden E, Yalcin K, Iliman N, Uzunalimoglu O and others (2002) Famciclovir treatment of chronic delta hepatitis. J Hepatol 37:266–271

    Article  PubMed  CAS  Google Scholar 

  • Zhu Y, Yamamoto T, Cullen J, Saputelli J, Aldrich CE, Miller DS, Litwin S, Furman PA, Jilbert AR, Mason WS (2001) Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol 75:311–322

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, 20007, USA

    J. L. Casey

  2. Department of Microbiology and Immunology and Division of Molecular Virology and Immunology, Georgetown University Medical Center, Washington, DC, 20007, USA

    J. L. Gerin

Authors
  1. J. L. Casey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. L. Gerin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Microbiology and Immunology, Georgetown University, 3900 Reservoir Road, NW, Washington, DC, 20007, USA

    John L. Casey Ph.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Casey, J.L., Gerin, J.L. (2006). The Woodchuck Model of HDV Infection. In: Casey, J.L. (eds) Hepatitis Delta Virus. Current Topics in Microbiology and Immunology, vol 307. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-29802-9_11

Download citation

Publish with us

Policies and ethics

Search

Navigation